Trial Profile
S-1 plus Oxaliplatin combination chemotherapy in a stop-and-go fashion for metastatic colorectal cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions
- Acronyms OPTISOX
- 15 Feb 2011 New trial record